Stockreport

Monte Rosa Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF BOSTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue d [Read more]